Delivery Order HHSD200201691776I-75D30118F00002
Award Date
9/30/18
Potential Completion Date
5/31/22
Potential Value
$1.9M
Federal Agency
CDC Pittsburgh
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27708, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Duke University Office of Research Administration Division was awarded a $467,417.49 firm fixed price delivery order against the Centers for Disease Control and Prevention's (CDC) Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract vehicle. The delivery order is for clinical immunization safety assessment services under Domain 1-A001 VE of the SHEPheRD 2011 program. Duke will perform...
The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
Duke University was awarded a $2,031,493.71 firm fixed price contract by the Centers for Disease Control and Prevention (CDC) to support Topic 2 of the FY 2020 COVID-19 Broad Agency Announcement. Performance will take place in Atlanta, GA through December 31, 2022. As prime contractor, Duke University will provide clinical research and immunization safety assessment services to the CDC under this award. The Institute for Medical Research, Inc., a nonprofit research organization supporting work...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a private university and non-profit organization, to provide clinical research and immunization safety assessment services. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $465,451.00 and was awarded on September 29, 2015, with a completion date...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $476,968.88 firm fixed price delivery order contract to Duke University to LEVERAGE NHSN AU OPTION TO INFORM, IMPLEMENT AND ASSESS ANTIBIOTIC STEWARDSHIP ACTIVITIES. The contract is part of the CDC's Safe Healthcare, Epidemiology, and Prevention Research Development Program (SHEPheRD) contract vehicle, and the work will be performed in Rockville, Maryland. No set-aside designation was indicated. As...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Duke University for the "LEAD SITE OPTIONAL TASK 1: BABIES COVID-19 VACCINATION" as a Delivery Order under the existing Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $970,063.00 and a period of performance through December 28, 2025. Duke University, a private university and non-profit...
This is a $1,268,329.00 delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Duke University on January 1, 2021. The contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) vehicle and is for the CISA COVID Pediatric Study Lead. The contract is a cost-no-fee arrangement and does not have any set-aside designations. Duke University's Office of Research Administration Division is serving as...
Duke University, as prime contractor, is providing clinical research and immunization safety assessment services under a cost-no-fee delivery order valued at $489,565. This award is issued against the prime IDIQ contract held by Duke University from the Centers for Disease Control and Prevention, entitled "Phase I Clinical Trials for Development of Neurotherapeutics", with a potential value of $86 million through September 2028. No set-aside designation was used for this delivery...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Duke University's Office of Research Administration Division. The $263,144.00 award is a delivery order under the CDC's Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract, which has a potential value of $86 million through September 2028. Under this contract, Duke University provides clinical research...